To study galcanezumab changes somatosensory perception exclusively in the face, whereas heat pain threshold before treatment predicts efficacy
Latest Information Update: 13 Jul 2022
At a glance
- Drugs Galcanezumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 07 Jul 2022 Results published in the Cephalalgia.
- 29 Sep 2021 New trial record
- 12 Sep 2021 Results presented at The International Headache Congress - International Headache Society with the European Headache Federation Joint Congress 2021